Published in Am J Surg on October 16, 2008
Combined approach for spontaneous rupture of hepatocellular carcinoma. World J Hepatol (2010) 1.08
Management of spontaneously ruptured hepatocellular carcinoma and hemoperitoneum manifested as acute abdomen in the emergency room. World J Surg (2012) 1.06
Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma. World J Gastroenterol (2014) 0.90
Prognostic factors of spontaneously ruptured hepatocellular carcinoma. World J Gastroenterol (2015) 0.88
Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience. HPB (Oxford) (2012) 0.84
Impact of spontaneous tumor rupture on prognosis of patients with T4 hepatocellular carcinoma. J Surg Oncol (2016) 0.82
Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study. Pak J Med Sci (2014) 0.81
One stage resection of spontaneous rupture of hepatocellular carcinoma in the triangular ligament with diaphragm invasion: case report and review of the literature. World J Emerg Surg (2012) 0.79
Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture. World J Gastroenterol (2014) 0.78
Gelatin sponge microparticles for the treatment of the spontaneous rupture of hepatocellular carcinoma hemorrhage. Exp Ther Med (2016) 0.76
Acute nontraumatic liver lesions. J Ultrasound (2013) 0.76
A Life-Saving Cancer: More on the Double Whammy. Tex Heart Inst J (2016) 0.75
Spontaneous hepatic haemorrhage: a review of pathogenesis, aetiology and treatment. HPB (Oxford) (2015) 0.75
Severe Anemia with Hemoperitoneum as a First Presentation for Multinodular Hepatocellular Carcinoma: A Rare Event in Western Countries. Case Reports Hepatol (2016) 0.75
Surgical resection of ruptured fibrolamellar hepatocellular carcinoma. Case Rep Surg (2013) 0.75
Hepatectomy for spontaneous rupture of hepatocellular carcinoma without portal triad clamping. Oncol Lett (2017) 0.75
Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med (2015) 3.47
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet (2011) 3.06
Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology (2008) 2.98
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91
Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81
Providing treatment to prisoners with mental disorders: development of a policy. Selective literature review and expert consultation exercise. Br J Psychiatry (2003) 2.79
Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl (2007) 2.59
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl (2013) 2.05
Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol (2003) 2.05
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology (2012) 2.01
Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00
Increasing burden of liver disease in patients with HIV infection. Lancet (2011) 1.98
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet (2012) 1.85
Liver disease in pregnancy. Lancet (2010) 1.84
Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut (2010) 1.83
Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl (2006) 1.82
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut (2011) 1.81
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol (2005) 1.79
Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology (2009) 1.77
Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol (2011) 1.74
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66
Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol (2003) 1.63
One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62
Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60
Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol (2006) 1.58
Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology (2006) 1.51
Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl (2013) 1.48
Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun (2011) 1.48
Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47
Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47
Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47
Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45
Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45
Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45
Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43
Diaphragmatic dysfunction after pediatric orthotopic liver transplantation. Transplantation (2002) 1.43
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
Live organ-donation for islet transplantation. Lancet (2005) 1.40
Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg (2004) 1.39
HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology (2006) 1.33
Human plasma fibrinogen is synthesized in the liver. Blood (2006) 1.27
Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry (2008) 1.18
Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18
The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15
Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Transplantation (2015) 1.13
Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13
Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12
Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol (2007) 1.12
Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem (2005) 1.11
Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10
Pseudoaneurysm following laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2007) 1.10
Emergency liver transplantation following severe liver trauma. Liver Transpl (2008) 1.09
Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand. Hepatology (2013) 1.09
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08
Transjugular biopsy of the liver in pediatric and adult patients using an 18-gauge automated core biopsy needle: a retrospective review of 410 consecutive procedures. AJR Am J Roentgenol (2003) 1.08
Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab. Liver Transpl (2005) 1.08
Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int (2007) 1.08
Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology (2013) 1.07
Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary Pancreat Dis Int (2010) 1.07
How we treat sickle hepatopathy and liver transplantation in adults. Blood (2014) 1.07
The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation (2004) 1.07
Liver transplantation for hepatocellular carcinoma with allografts from donors after circulatory death: is the tumor recurrence genuinely increased? Liver Transpl (2014) 1.06
Cholangiopathy and the biliary cast syndrome. Eur J Gastroenterol Hepatol (2003) 1.06
Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation (2003) 1.06